WAY

Waystar Holding Corp. 10-Q Summary: Q2 2024

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2024. Waystar Holding Corp. is a provider of mission-critical cloud technology for healthcare organizations, focusing on payment processing and reconciliation. The company completed its Initial Public Offering (IPO) in June 2024, issuing 45 million shares at $21.50 per share. Following the IPO, the company is classified as an emerging growth company and a non-accelerated filer.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 19.7% quarter-over-quarter and 18.7% year-over-year (YTD). Growth was driven by volume-based revenue (up 26.2% QoQ) and subscription revenue (up 13.1% QoQ). A competitor's cybersecurity incident in February 2024 contributed an estimated $9 million to Q2 revenue due to accelerated client onboarding.
• Expense Increases: Operating expenses rose significantly, primarily due to non-cash stock-based compensation (SBC). SBC expense jumped from $2.1 million in Q2 2023 to $37.0 million in Q2 2024, largely due to the acceleration of performance condition options upon the IPO. General and Administrative expenses increased 176% QoQ.
• Net Loss Expansion: Net loss widened to $27.7 million in Q2 2024 from $10.8 million in Q2 2023. This was driven by the aforementioned SBC acceleration and debt extinguishment costs, despite a 3.5% operating margin.
• Debt Reduction: The company utilized IPO proceeds to repay $909.1 million of its First Lien Credit Facility in June 2024. Subsequent to the quarter end (July 2024), an additional $110.9 million was repaid. The Second Lien Credit Facility was fully paid down in February 2024.

Guidance, Outlook, and Risks

• Outlook: Management expects to incur approximately $17.9 million annually in SBC related to IPO grants. The company anticipates lower interest expense moving forward due to debt paydowns, partially offset by one-time extinguishment losses.
• Key Performance Metrics: Net Revenue Retention Rate was 107.5% for the twelve months ended June 30, 2024. The company serves over 30,000 clients, with 1,117 clients generating over $100,000 in revenue annually.
• Risks: Key risks include the highly competitive healthcare technology landscape, reliance on third-party vendors, cybersecurity threats, and the impact of evolving healthcare regulations. The company also faces risks related to its ability to retain clients and successfully integrate future acquisitions.
• Unusual Items: The Q2 results include significant one-time charges related to the IPO, including $9.8 million in debt extinguishment costs and $33.1 million in accelerated SBC. These items are excluded from Adjusted EBITDA.

Investor Verification Checklist

• Debt Covenants: Verify compliance with the amended First Lien Credit Facility covenants following the significant principal paydowns.
• SBC Sustainability: Assess the long-term impact of the $33.1 million SBC acceleration on future profitability and cash flow projections.
• Competitor Impact: Evaluate the sustainability of the revenue growth attributed to the competitor's cybersecurity incident; determine if this represents a permanent market share shift or a temporary spike.
• Cash Flow Trends: Monitor the decline in operating cash flow (down 48% YTD) to ensure it is not a structural issue but rather a timing difference related to working capital and tax payments.
• Subsequent Events: Confirm the utilization of the additional $102.8 million in proceeds from the underwriters' option exercise (July 2024) for further debt reduction.